Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07cbd4e52fb34686154eace1c33b1208 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 |
filingDate |
2022-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62fc9365fa04e2c87f094056725fd16e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4990c672e1320a14eb761ee867f8dc83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b28674af4335073b2aaa1542e4dbac9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c10b11665e4966bafe27c61cad4c19d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dd9c5e29a72fe20ff327e14cbb0572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8798d13f33040ec0be29acbe84cb917 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7574ec5455db7f4e320cc77d6fe00ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a4c728e70f548b6b7b37aa51decddc0 |
publicationDate |
2022-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022249695-A1 |
titleOfInvention |
Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same |
abstract |
POZ-lipid conjugates and lipid nanoparticles (LNPs) including POZ-lipid conjugates used to facilitate delivery of an encapsulated payload. LNPs including POZ-lipid conjugates and a nucleic acid payload such as, but not limited to, mRNA or modified mRNA are disclosed. Such LNPs have no immunogenicity or reduced immunogenicity as compared to a corresponding LNP containing a PEG-lipid. |
priorityDate |
2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |